| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 11.66B | 10.68B | 10.13B | 9.83B | 9.72B | 13.88B |
| Gross Profit | 4.38B | 3.94B | 3.80B | 3.66B | 3.50B | 5.20B |
| EBITDA | 3.98B | 2.90B | 3.38B | 2.90B | 2.88B | 5.02B |
| Net Income | 2.67B | 382.00M | 1.45B | -6.66B | -16.72B | 417.00M |
Balance Sheet | ||||||
| Total Assets | 43.48B | 33.49B | 33.78B | 54.97B | 63.28B | 82.93B |
| Cash, Cash Equivalents and Short-Term Investments | 755.00M | 599.00M | 834.00M | 440.00M | 456.00M | 2.01B |
| Total Debt | 4.26B | 4.01B | 11.54B | 19.34B | 20.41B | 20.88B |
| Total Liabilities | 27.50B | 19.59B | 18.08B | 35.92B | 35.87B | 35.40B |
| Stockholders Equity | 15.98B | 13.90B | 15.70B | 19.05B | 27.22B | 47.35B |
Cash Flow | ||||||
| Free Cash Flow | 2.78B | 2.81B | 1.97B | 4.22B | 3.67B | 3.56B |
| Operating Cash Flow | 2.95B | 2.96B | 2.07B | 4.33B | 3.94B | 4.81B |
| Investing Cash Flow | -9.72B | -3.19B | 8.14B | -1.52B | -373.00M | -1.77B |
| Financing Cash Flow | 6.74B | -1.18B | -12.62B | -3.32B | -2.57B | -2.54B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | $9.93B | 23.14 | 24.03% | 1.25% | 8.44% | 21.74% | |
73 Outperform | $22.07B | 2.55 | 18.45% | 2.40% | 12.27% | 222.91% | |
72 Outperform | $17.26B | 17.10 | 40.06% | 1.63% | 8.19% | 40.01% | |
71 Outperform | $4.40B | 27.28 | 13.99% | ― | 7.06% | -22.01% | |
65 Neutral | $19.36B | -2.24 | -3.07% | 1.25% | -12.55% | -39.16% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
61 Neutral | $30.08B | 13.08 | 12.51% | ― | 1.87% | 3.79% |